GPTKB
Browse
Query
Compare
Download
Publications
Contributors
Search
Takeda Pharmaceutical Company
URI:
https://gptkb.org/entity/Takeda_Pharmaceutical_Company
GPTKB entity
Statements (90)
Predicate
Object
gptkbp:instanceOf
gptkb:biotechnology
gptkbp:acquiredBy
gptkb:Shire_plc
gptkbp:acquisitionYear
2019
gptkbp:CEO
gptkb:Christophe_Weber
gptkbp:country
gptkb:Japan
gptkbp:ESRB_rating
gptkb:A_(MSCI,_2023)
gptkbp:foundedBy
gptkb:Chobei_Takeda_I
gptkbp:foundedIn
1781
gptkbp:founder
gptkb:Chobei_Takeda_I
gptkbp:hasResearchCenter
gptkb:Europe
gptkb:Japan
gptkb:United_States
gptkbp:headquartersLocation
gptkb:Nihonbashi,_Chuo-ku,_Tokyo,_Japan
https://www.w3.org/2000/01/rdf-schema#label
Takeda Pharmaceutical Company
gptkbp:industry
pharmaceuticals
gptkbp:keyPerson
gptkb:Julie_Kim_(President,_Plasma-Derived_Therapies_Business_Unit)
Andrew Plump (President, R&D)
Christophe Weber (President & CEO)
Costa Saroukos (Chief Financial Officer)
Masato Iwasaki (President, Japan Pharma Business Unit)
Ramona Sequeira (President, Global Portfolio Division)
gptkbp:listedOn
gptkb:Nikkei_225
gptkb:TOPIX_Core30
gptkbp:logo
Takeda Pharmaceutical Company logo.svg
gptkbp:marketCap
~$50 billion (2023)
gptkbp:memberOf
gptkb:Japan_Pharmaceutical_Manufacturers_Association
gptkb:Pharmaceutical_Research_and_Manufacturers_of_America
gptkb:European_Federation_of_Pharmaceutical_Industries_and_Associations
gptkbp:memberState
over 80
gptkbp:netIncome
307.9 billion yen (FY2022)
gptkbp:notableProduct
gptkb:Zanidip
gptkb:Magnevist
gptkb:Zoladex
gptkb:Alunbrig
gptkb:Rozerem
gptkb:Zofran
gptkb:Adcetris
gptkb:Actos
gptkb:Aloxi
gptkb:Azilva
gptkb:Blopress
gptkb:Colcrys
gptkb:Dexilant
gptkb:Ebrantil
gptkb:Entyvio
gptkb:Gammagard
gptkb:Lupron
gptkb:Natpara
gptkb:Ninlaro
gptkb:Uloric
gptkb:Velcade
gptkb:Vyvanse
gptkb:Lansoprazole
gptkb:Pantoprazole
gptkb:TAKHZYRO
gptkbp:numberOfEmployees
~49,000
gptkbp:parentCompany
none (independent)
gptkbp:products
oncology drugs
prescription drugs
vaccines
plasma-derived therapies
gastroenterology drugs
rare diseases drugs
gptkbp:revenue
3.569 trillion yen (FY2022)
gptkbp:servesArea
worldwide
gptkbp:slogan
Better Health, Brighter Future
gptkbp:stockExchange
gptkb:New_York_Stock_Exchange
gptkb:Tokyo_Stock_Exchange
gptkbp:stockSymbol
gptkb:TAK
4502
gptkbp:subsidiary
gptkb:Takeda_Oncology
gptkb:Shire_(acquired)
gptkb:Takeda_Ventures
Nycomed (acquired)
gptkbp:type
public (K.K.)
gptkbp:website
https://www.takeda.com/
gptkbp:世界排名
largest pharmaceutical company in Asia
one of the top 20 pharmaceutical companies worldwide
gptkbp:bfsParent
gptkb:Dentsu_Inc.
gptkb:Nihombashi
gptkb:Takeda_Foundation
gptkb:famotidine
gptkb:Hanshin_Industrial_Region
gptkb:Adcetris
gptkb:lansoprazole
gptkb:relugolix
gptkb:PhRMA
gptkb:Qdenga
gptkb:Τόκιο
gptkbp:bfsLayer
6